相关实验视频

Updated: May 17, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

诱导神经元中的转录基因组和表观基因组的细胞类型特定的全球重编程,具有16p11.2神经精神病 CNVs

Thomas R Ward^1,2, Ping-Ping Qu^1,2, Louis C Leung^1,3

¹Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.

European journal of human genetics : EJHG

|May 15, 2025

概括

拷贝数变异 (CNVs) 在16p11.2改变基因表达和DNA甲基化,影响神经发育障碍. 这项研究揭示了删除和重复载体的共享基因组变化,确定PCSK9是潜在的因素.

科学领域:

基因组学就是基因组学.
神经科学是一个神经科学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

16p11.2副本数变异 (CNVs) 与自闭症谱系障碍 (ASD) 和精神分裂症有关.
了解这些神经发育条件背后的分子机制至关重要.

研究的目的:

研究来自16p11.2 CNV患者的诱导神经元中的全基因组基因表达和DNA甲基化变化.
为了确定与16p11.2 CNVs.相关的表型有助于特定的基因和途径.

主要方法:

利用来自 16p11.2 CNV 患者和对照者的诱导多能干细胞 (iPSC),将其分化为诱导神经元 (iNs).
进行全基因组转录组和DNA甲基组分析以确定变化.
基因表达和甲基化模式在删除和重复的CNV携带者和对照者之间进行比较.

主要成果:

在16p11.2 CNV iNs.中揭示了转录组和DNA甲基组的全球重编程.
在删除和重复载体中确定了共享的,全基因组差异表达的基因和差异甲基化区域.
突出显示PCSK9是潜在的贡献基因,并且在protocadherin (PCDH) 基因家族中改变了DNA甲基化.

结论:

16p11.2 CNV 诱导广泛的,细胞类型特定的表观遗传和转录基因变化.
这些变化为与16p11.2 CNVs相关的神经发育障碍的分子病因提供了洞察力.
可用的iPSC线路是未来研究的宝贵资源.

更多相关视频

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

相关概念视频

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Introduction to Nuclear Reprogramming

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...